Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1986-5-1
pubmed:abstractText
To investigate whether the hypotensive and bradycardiac effects of B-HT 958 (2-amino-6-(p-chlorobenzyl)-4H-5,6,7,8-tetrahydrothiazolo-(5,4-d) azepine) are due to the stimulation of peripheral prejunctional alpha2-adrenoceptors, the selective alpha2-adrenoceptor antagonist idazoxan was given either intravenously (i.v.) or intracerebroventricularly (i.c.v.) to anaesthetized rats before the administration of i.v. B-HT 958. Plasma noradrenaline was used as an approximate index of peripheral sympathetic nervous activity. B-HT 958 350 micrograms kg-1 i.v. caused significant falls in blood pressure and heart rate which were maximal 5 min after dosing (-29.25 +/- 3.2 mmHg and - 52 +/- 6.8 beats min-1 respectively, mean of all control animals). The hypotension and bradycardia were accompanied by significant falls in plasma noradrenaline concentration of 30-40%. Idazoxan 300 micrograms kg-1 i.v. caused a marked, but transient tachycardia and a large sustained rise in plasma noradrenaline concentration. Idazoxan 300 micrograms kg-1 and 1000 micrograms kg-1 i.v. did not prevent B-HT 958-induced falls in mean arterial pressure, heart rate and plasma noradrenaline concentration. Responses to B-HT 958 were unaffected by idazoxan 20 micrograms i.c.v. B-HT 958-induced falls in mean arterial pressure, heart rate and plasma noradrenaline concentration were significantly attenuated by i.v. administration of the dopamine receptor antagonist, sulpiride 300 micrograms kg-1. Sulpiride 10 micrograms and 50 micrograms i.c.v. caused inhibition of B-HT 958 hypotension and bradycardia similar to that of intravenous sulpiride. After i.c.v. sulpiride, B-HT 958 did not cause a significant fall in plasma noradrenaline concentration. A combination of idazoxan 1000 micrograms kg-1 i.v. and sulpiride 300 micrograms kg-1 i.v. did not cause further significant inhibition of B-HT 958 hypotension and bradycardia compared with sulpiride 300 micrograms kg-1 i.v. alone. This combination however had a significantly greater effect in inhibiting B-HT 958 hypotension than had idazoxan 1000 micrograms kg-1 alone, and almost completely blocked the B-HT 958-induced fall in plasma noradrenaline concentration. These results suggest that in the anaesthetized rat the cardiovascular effects of B-HT 958 are due to stimulation of dopamine receptors, probably located within the central nervous system, and not to stimulation of peripheral prejunctional alpha2-adrenoceptors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-22821, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-38331, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-477731, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6089003, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6106139, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6112262, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6116802, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6117656, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6126817, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6132640, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6135163, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6138716, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6141948, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6144048, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6150737, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6150978, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6152218, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6245898, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6296699, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6301216, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-645884, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6459500, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6707926, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6752615, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-6755118, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-7155198, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-7192314, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-7252851, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-7274328, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-7285505, http://linkedlifedata.com/resource/pubmed/commentcorrection/3006858-7379260
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
361-70
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't